0 followers
Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics. The company’s lead product, Tegavivint, is a potent and selective inhibitor of the Wnt/b-catenin signaling pathway, implicated in cell proliferation, differentiation, immu... Read more
Rahul Aras
This company has no teams yet
Amgen
235 followers
Charlie Health
6 followers
Calico
6 followers
ARS Pharmaceuticals
1 follower
Watchmaker Genomics
3 followers
Madrigal Pharmaceuticals
2 followers
Tessera Therapeutics
2 followers
Caribou Biosciences
2 followers
Vera Therapeutics
2 followers
Immunome
2 followers
EpiVax, Inc.
2 followers
Explore companies